Ministry of Coal organises BRICS Side Event on Clean Coal Technologies (See 'Corp Brief') 100 Startups from 22 States complete Export-Focused Acceleration Programme (See 'Corp Brief') MoS pitches 'BRICS Space Economy' (See 'Corp Brief') SEBI -Failure to file Quarterly Activity Reports for multiple consecutive quarters constitutes violation of regulatory framework & attracts consequences prescribed under Regulation 35 of AIF Regulations, 2012: SEBI (See 'Legal Desk') IPC successfully conducts Training on Ethylene Glycol & DEG in Preparations by Gas Chromatography (See 'Corp Brief') Unlocking Potential of Idle Financial Assets in India (See 'Corp Brief') SARFAESI - In absence of any adjudication by the DRT in determining the debt, statutory scheme permits reliance upon claim made by secured creditor for purpose of fixing pre-deposit: HC (See 'Legal Desk') CCI okays acquisition of shares in Nxtra Data by Alpha Wave Ventures (See 'Corp Brief') CCI okays acquisition of 21% voting interest in Astemo Ltd. by Honda Motor (See 'Corp Brief') FEMA - Claims & liabilities pertaining to periods prior to approval of resolution plan, which do not survive under approved plan, are extinguished & cannot be enforced: SAFEMA (See 'Legal Desk') Special Drive launched for expeditious Disposal of Long-Pending Labour Cases (See 'Corp Brief') Amit Shah to launch NAFED's auction portal 'NAFEX.in' (See 'Corp Brief') SEBI - A judicial pronouncement cannot ordinarily be modified or reviewed through post-disposal miscellaneous application; Tribunal becomes functus officio upon disposal of appeal: SAT (See 'Legal Desk') Railways approves Kavach Deployment Worth Rs.270 Crore on East Coast (See 'Corp Brief') DIBD and AISF sign MoU to promote Language Technology and Multilingual Innovation in Assam (See 'Corp Brief') IPR - Injunction allowed as defendant's adoption of marks is not honest or bona fide; marks are deceptively similar to plaintiff's registered trademark, such that an average consumer with imperfect recollection would likely be confused: HC (See 'Legal Desk') NMDC accelerates Digitalisation and Sustainable Mining to support 100 MTPA Vision (See 'Corp Brief') Union Minister sanctions over 42,000 houses in MP; 38,000 families perform grih pravesh (See 'Corp Brief') A&C - Where a Section 34 court has already examined the award, a possible alternative interpretation of the contractual clause is insufficient to justify interference: HC (See 'Legal Desk') Tech Innovation and disruption in Construction Industry (See 'CORP EINSICHT') Union Minister reviews Power Sector and Urban Development Schemes with Jharkhand Govt (See 'Corp Brief') APEDA facilitates First Export of fresh Uttarakhand Litchi to Italy (See 'Corp Brief') Trade Marks - Quasi-judicial authority cannot validly base its decision on grounds that were not specifically disclosed in SCN, thereby depriving noticee of an effective opportunity to respond: HC (See 'Legal Desk') Nadda calls for Push towards a TB-Free India (See 'Corp Brief') India must take control of security-related necessities to remain future-ready: RM (See 'Corp Brief') A&C - Financial hardship cannot justify payment of disputed amount linked to fulfilment of deliverable-based obligations: HC (See 'Legal Desk')

IPC successfully conducts Training on Ethylene Glycol & DEG in Preparations by Gas Chromatography

Published: Jun 25, 2026

By TIOLCorplaws News Service

NEW DELHI, JUN 25, 2026: THE Indian Pharmacopoeia Commission (IPC) successfully conducted the 2nd Hands-on Training Programme on the Determination of Ethylene Glycol (EG) and Diethylene Glycol (DEG) in Oral Liquid Preparations by Gas Chromatography (GC) from 22nd to 23rd June 2026 at its campus in Ghaziabad.

The training programme was inaugurated by Dr V. Kalaiselvan, Secretary-cum-Scientific Director, IPC, in the presence of Rajeev Bhargava, Deputy Drugs Controller (DDC), Department of Drugs Control, Delhi, who graced the occasion as the Guest of Honour. During the inaugural session, the importance of strengthening analytical capabilities of regulatory laboratories for ensuring the quality, safety, and efficacy of medicines was emphasized.

The two-day programme brought together participants from six states including Haryana, Goa, Odisha, West Bengal, Assam, and Meghalaya, and provided intensive practical training on the determination of EG and DEG in oral liquid formulations using Gas Chromatography. The participants received hands-on exposure to sample preparation, instrument operation, calibration, analytical method implementation, chromatogram interpretation and data analysis.

Ethylene Glycol (EG) and Diethylene Glycol (DEG) are highly toxic substances that are not permitted in pharmaceutical formulations. These contaminants may be introduced through adulterated or substandard excipients such as glycerin, propylene glycol, sorbitol, and polyethylene glycol. Even trace quantities can pose serious health risks, including acute kidney injury, central nervous system depression, and death. Therefore, their accurate detection, quantification, and control are essential for safeguarding public health and ensuring pharmaceutical quality.

The training programme was organized in the context of Amendment List 09 to IP–2022, effective from 10th October 2025, which mandates testing for Ethylene Glycol (EG) and Diethylene Glycol (DEG) in all oral liquid formulations. Through this initiative, IPC continues to support the effective implementation of Indian Pharmacopoeia standards and strengthen the analytical preparedness of State Drug Testing Laboratories across the country.

The technical sessions covered the scientific basis of DEG and EG contamination, regulatory requirements, analytical methodology, and practical application of Gas Chromatography for routine testing. Participants also gained insights into potential sources of contamination and the critical role of quality control measures in preventing the entry of toxic contaminants into pharmaceutical products.

The programme significantly enhanced the technical competence of government drug analysts and facilitated knowledge sharing among regulatory laboratories. The hands-on approach enabled participants to develop practical skills required for accurate analysis and compliance with pharmacopoeial requirements.

The Indian Pharmacopoeia Commission remains committed to providing technical support, capacity building, and specialized training to State and Union Territory Drug Testing Laboratories to facilitate effective implementation of Indian Pharmacopoeia standards and strengthen the regulatory framework for ensuring the availability of safe, effective, and quality medicines to the public.

TIOL CORP SEARCH

TIOL GROUP WEBSITES